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ABSTRACT A rat hepatoma cell line (Q7) of Morris
hepatoma origin was transfected with a construct containing
the tandem dimer genome of human hepatitis B virus (HBV)
and the neomycin-resistant selection marker. The culture
medium of several neomycin-resistant single-cell clones was
found to accumulate high levels of secreted HBV surface
antigen and core-related e antigen. HBV-specific replication
intermediates, including relaxed circular and single-stranded
DNA with a minus-strand polarity, could be found in both the
intracellular fraction and the extracellular culture medium by
the Southern blot procedure. One of these clones, designated
Q7 HBV-21, was characterized in further detail. DNA poly-
merase activity was present in the virus particles produced by
Q7 HBV-21 cells. Characteristic transcripts of HBV, including
the 3.5-, 2.5-, and 2.1-kilobase mRNA as well as a core-gene-
related transcript of 2.2 kilobases could be detected. Electron
microscopic examination of the conditioned medium from Q7
HBV-21 cells identified 42-nm Dane-like particles as well as
22-nm subviral particles with a spherical or filamentous shape.
This Q7 HBV-21 cell line has been maintained in the absence
of neomycin for 1 year without losing the properties of HBV
DNA replication and Dane-like particle production. Our re-
sults strongly suggest that the species barrier ofHBV infection
is at an early step of viral absorption onto or penetration into
the target hepatocytes. This nonhuman system for HBV pro-
duction in culture could be used to complement the human
HepG2 system.
Research on human hepatitis B virus (HBV) has been ham-
pered by the slow development of a tissue culture system for
HBV propagation (1-3). It is possible to study HBV produc-
tion in culture by using human hepatoma cell lines HepG2 (4,
5) or Huh6-c15 (6) and stable transfection techniques. In
addition, the human hepatoma cell line Huh7 was used as a
recipient for production of HBV through the transient trans-
fection technique (7, 8). In all these studies, HBV-specific
DNA replication intermediates were identified. Moreover,
characteristic subviral and matured viral particles (Dane
particles) were observed by electron microscopy. These viral
particles produced by HepG2 cells were later shown to be
infectious in chimpanzees (9, 10).
HBV is a member of the so-called hepadnavirus family
including hepatitis B viruses of woodchucks, ground squir-
rels, tree squirrels, Pekin ducks, etc. (1-3). Members of the
hepadnavirus family in general exhibit a rather strict host
range. For example, HBV is known to replicate only in
humans and chimpanzees. It has been reported that infec-
tious particles of duck hepatitis B virus can be generated by
transient gene transfer to the established human hepatoma
cell lines HepG2 (11, 12) and Huh7 (12, 13). Although these
experiments demonstrated that duck hepatitis B virus can
replicate and mature in certain human hepatoma cell lines, it
remains unclear if the converse is true-i.e., if HBV can
propagate and mature into infectious Dane particles in a
nonhuman hepatoma system. For example, although ground
squirrel hepatitis virus can grow in eastern woodchucks, it
has not been possible to grow woodchuck hepatitis virus in
ground squirrels (14). In fact, attempts to grow HBV in
mouse fibroblasts were made but no mature virions were
observed (15). It is unclear if this failure was due to the
species barrier, the tissue-type barrier, or both. However,
successful replication of the complete genome HBV was
observed in a transgenic mouse obtained after injection of
head-to-tail dimers of the HBV genome (16). However, no
completely matured Dane particles were observed in this
transgenic mouse system (16).
To address the issues of cellular permissiveness and host
range determination and to establish a nonhuman HBV-
producing system in culture, we have screened, by a transient
transfection assay, various HBV recipients of nonhuman
origin for the ability to support HBV replication. Q7, a rat
hepatoma cell line, was found to be competent to support
HBV replication and maturation. Subsequently, stable trans-
fection techniques have allowed us to establish a series of
HBV-producing Q7 rat hepatoma cell lines.
To our knowledge, this is the first demonstration that
Dane-like particles of HBV can be produced in a nonhuman
cell culture system. These results have been presented
previously.§
MATERIALS AND METHODS
Construction of Donor DNA. An HBV-containing plasmid,
pcpl0, was a generous gift from P. Tiollais (Pasteur Institute)
(17). This plasmid DNA was linearized with EcoRI. The
resulting 3.1-kilobase (kb) HBV DNA fragment was electro-
eluted from the gel and ligated with EcoRI-digested
pSV232ANeo vector DNA (18). This ligated DNA mixture
was transformed into TG1 Escherichia coli. A test for
PSV2ANeo-HBV monomer was done by EcoRI digestion of
miniprep DNA. A partial digestion of a pSV2ANeo-HBV
monomer DNA with EcoRI was then conducted. The linear-
ized 9.3-kb band was electroeluted from a gel and ligated to
an EcoRI-cleaved 3.1-kb HBV DNA insert. Preparations of
plasmid DNA from transformed colonies were screened for
head-to-tail dimers by digestion with Xho I, which should
give the 3.1-kb HBV DNA insert upon cleavage of HBV
dimer DNA.
Abbreviations: HBV, human hepatitis B virus; ccc, covalently
closed circular; rc, relaxed circular; ss, single-stranded; e/core, HBV
core or e antigen; Neor, neomycin resistance(t).
tTo whom reprint requests should be addressed.
§Li, L.-S. & Shih, C., Molecular Biology of Hepatitis B Viruses,
Aug. 7-11, 1988, University of California at San Diego, La Jolla,
CA, p. 37.
6323
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 86 (1989)
Transfection and Cell Culture. The rat hepatoma cell line
Q7 was kindly provided by J. Chou (National Institutes of
Health, Bethesda, MD) and maintained in 5-10%o (vol/vol)
fetal bovine serum in Dulbecco's modified Eagle's medium,
at 370C in an atmosphere of5.5% C02/94.5% air. The calcium
phosphate transfection procedure was used as described (19).
Briefly, 7 x 105 cells per 10-cm dish were transfected with
5-10 Ag of pSV2ANeo-(HBV)2 DNA plus 20 gg of human
genomic DNA as carrier. Donor DNA was removed 4 hr after
transfection. Neomycin-resistant (Neo9) colonies were iso-
lated 4 weeks later. G418 was removed from medium 3
months after transfection.
Detection of e or Core (e/core) and Surface Antigens.
Conditioned medium from Neor Q7 cell lines was assayed
according to suppliers' recommendations [Abbott enzyme
immunoassay (EIA) kit for e/core antigen and RIA kit for
surface antigen].
Fractionation of Extracellular HBV Particles. Conditioned
medium (80 ml) from each sample was precleared at 2500 rpm
(Sorvall SS34 rotor) for 10 min at 40C. Particles from 27 ml of
cell-free medium were pelleted through an 11-ml 20% (wt/
vol) sucrose cushion in TNE buffer (150 mM -NaCl/20 mM
Tris HCl/1 mM EDTA) in an SW 28 rotor at 25,000 rpm for
16 hr at 4°C. Each pellet was resuspended in 0.5 ml of TNE
buffer, loaded onto a 20-50%6 (wt/vol) cesium chloride iso-
pycnic gradient in TNE buffer and centrifuged using an SW
50.1 rotor at 35,000 rpm at 4°C for 16 hr. After centrifugation,
0.3-ml fractions were collected from the bottom of the tube.
The density of the fractions was monitored with a refracto-
meter and ranged from -1.130 g/ml to 1.386 g/ml.
Electron Microscopy. Putative Dane particle-containing
fractions from a cesium chloride gradient were pooled and
dialyzed into TNE buffer using a Centricon-10 concentrator
(Amicon). Starting with 80 ml ofconditioned medium, 50-100
,ul ofa concentrated particle fraction was produced. About 10
,l was applied to each Formvar-coated grid, followed by
washing with six drops of 0.1 M ammonium acetate (pH 7.2)
and staining with freshly filtered 1% uranyl acetate. The
JEOL model 4000EX electron microscope was used for
photography.
DNA and RNA Analysis. Genomic DNA was prepared as
described (20). The Hirt extraction protocol was adopted
from Hirt (21). RNA was prepared according to Chirgwin et
al. (22). Southern and Northern blot analyses followed stan-
dard procedures (23).
Polymerase Assay. Polymerase activity was analyzed by
standard procedures (5).
RESULTS
e/core Antigen Screening of Transiently Transfected Rat
Hepatoma Cell Lines. To investigate cellular permissiveness
of HBV propagation, it was important to find cell lines in
addition to HepG2 that were also competent to produce
HBV. We, therefore, screened -10 hepatoma cell lines by
transfecting with a tandem dimer of HBV genome and then
assaying for secreted e/core antigen in the medium (Abbott
EIA kit for e/core antigen). These cell lines include rodent
hepatoma NI-SI (ATCC CRL 1604), H4-II-E (ATCC CRL
1548), MHICI (ATCC CCL 144), McA-RH7777 (ATCC CRL
1601), MCA-RH 8994 (ATCC CRL 1602), H4-II-E-C3 (ATCC
CRL-1600), HTC (24), and Q7 (a clonal derivative of McA-
RH7777) as well as human hepatoma lines FOCUS (25) and
HepG2 (26). Among these cell lines, only McA-RH-7777 (27),
Q7, and HepG2 exhibited detectable level of e/core antigen
=24 hr after transfection (data not shown). We attempted,
therefore, to establish a stably transfected Q7 cell line that
supported HBV production.
Stable Transfection of the Rat Hepatoma Cell Line Q7. By
using the calcium phosphate protocol (19), -106 Q7 cells
were transfected with a tandem dimer of the HBV genome in
a simian virus 40 vector that also contains a neomycin-
resistance marker. Transfected cultures were selected with
G418 30 hr later. To obtain a more effective killing, the dosage
of G418 was increased from Geneticin (GIBCO) at 1 mg/ml
to 1.2 mg/ml at the beginning of the third week after trans-
fection. Colonies were subcultured into 35-mm dishes during
the fifth week. Geneticin was removed from culture -3
months later. A transfection efficiency of 4 x 1O-5 colonies
per cell per 10 ,g of donor DNA was observed in this Q7 rat
hepatoma system.
Enzyme Immunoassay of Secreted e/core Antigen and Sur-
face Antigen. The conditioned medium ofNeor Q7 clones was
collected and assayed for HBV-specific sero markers, such
as e/core and surface antigens. When the enzyme immu-
noassay kits of Abbott were used, significant amounts of
antigen were detected (Table 1). Since the e/core antigen is
a marker often associated with active viral replication (1-3),
we chose to characterize those clones with higher titer of
e/core antigen production or secretion. According to our
rough estimate using the Abbott Auszyme monoclonal EIA
kit, cell line Q7 HBV-21 was able to produce surface antigen
at -5.25 ug per 107 cells per 24 hr.
Characterization of HBV-Specific DNA Replication Inter-
mediates. The synthesis of hepadnavirus DNA is known to
involve reverse transcription of an RNA intermediate (28).
During the replication cycle, characteristic intermediates in
DNA can be identified within infected cells, including the
molecular forms of relaxed circular (rc) and the single-
stranded (ss) DNA with minus-strand polarity (1-3). Low
molecular weight, unintegrated DNA was extracted from our
Q7 lines (21) and analyzed by the Southern blotting procedure
Table 1. Serological markers of the surface and e/core antigens
of HBV assayed by enzyme immunoassay using conditioned
medium from HBV DNA-transfected Q7 rat hepatoma cell lines
HBV antigen, S/N ratio
Hepatoma
cell lines
Q7 HBV-1
Q7 HBV-2
Q7 HBV-4
Q7 HBV-5
Q7 HBV-6
Q7 HBV-7
Q7 HBV-9
Q7 HBV-12
Q7 HBV-14
Q7 HBV-18
Q7 HBV-19
Q7 HBV-21
Q7 HBV-23
Q7 HBV-25
Q7 parental
DNA
e/core Surface intermediates
4.6
7.5
14.9
6.8
0.3
14.1
13.0
4.8
16.6
9.2
12.7
5.4
8.4
0.8
0.4
>37.0
>37.0
>37.0
28.6
0.1
>37.0
>37.0
>37.0
>37.0
15.8
>37.0
>37.0
<0.1
>37.0
<0.1
+
+
+
+
+
++
Stable HBV-producing and parental rat hepatoma cell lines were
used. Three-day conditioned medium collected from plates with
20-100%o confluency of cell density was analyzed with the Abbot
enzyme immunoassay (EIA) kit. Procedure A was used for the
measurement of secreted surface antigens. The results of surface
antigen detection by enzyme immunoassay are consistent with those
by radioimmunoassay (data not shown). The e/core antigen results
represent two independent measurements at different times. The
difference in the titer may reflect in part some difference in the cell
density. The intracellular HBV-specific DNA was prepared as de-
scribed by Hirt (21). S/N ratio, signal/noise ratio; +, DNA replica-
tion intermediate present; -, DNA replication intermediate not
detected. For the S/N ratio for HBV e/core antigen, values of
negative range from 0.030 to 0.090, and the cutoff was 0.120. For the
S/N ratio for HBV surface antigen, values of negative range from
0.001 to 0.013, and the cutoff was 0.054.
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(23). Intense banding around positions 4.0 kb (rc) and 1.5 kb
(ss) was evident in several cell lines including Q7 HBV-2, -4,
-5, -14, -19, and -21 (only part of the data is shown in Fig. 1A).
The high molecular weight DNA band at the 23-kb position
is due to the trace contamination ofundigested chromosomal
DNA containing integrated HBV in these Hirt DNA prepa-
rations (Fig. 1A). The ss nature of the 1.5-kb band was
confirmed by direct transfer to a nitrocellulose membrane
without prior alkaline denaturation (Fig. 1B). The ssDNA
was shown to be of minus-strand polarity by hybridization to
strand-specific probe ofHBV DNA cloned in an M13 vector
A 1 2 34 5
:r_ P..w23kb B
- 9.8 kb
-.Kw6.6 kb
-4.3 kb
RC4kb___.
3.1 kb _R
-2.3 kb
,|, -.2.0kb
SS(-)1.5kb3- -
12 3 4
SS(-)1I5kb-
1 2 3 49.8kb'-
6.6kbs-
4.3kb --
-aRC
2.3kbm.-
2.0kb'-
(Fig. 1B). Depending on the DNA preparations, another
signal of ssDNA intermediates could sometimes be seen at
-1.3 kb (data not shown).
The covalently closed circular (ccc) form of HBV DNA
was not detected in these HBV-producing cell lines, either
alone or in the presence of proteinase K during the DNA
preparation procedure (see Discussion). The bands that were
detected represent HBV replicative intermediates of various
length. Although we have noted the presence of one or two
extra bands in these zebra patterns in HBV-producing rat
hepatoma cell lines (Fig. 1A, lanes 4 and 5), these bands (at
-2.6 kb and -2.3 kb) can sometimes be found as well in the
HBV-producing human HepG2-derived cell lines UP7-4 or
UP7-7 (unpublished results). According to-our rough esti-
mate, each cell of Q7 HBV-21 contains -50 copies of
unintegrated HBV DNA.
Extracellular DNA. Ten milliliters of 3-day conditioned
medium from Q7 HBV-21 cells was collected and passed
through a filter to remove any cellular contamination. The
particles in the cell-free filtrate were pelleted by centrifuga-
tion and resuspended in TNE buffer. The 4.0-kb rcDNA and
the 1.5-kb ssDNA can be seen by Southern blot analysis (Fig.
1C), indicating that the complete virion of Dane particles and
probably the less matured core particles were also present in
the medium. The banding pattern of the extracellular DNA
appears to be identical to the intracellular, unintegrated HBV
DNA (Fig. 1 A and C).
Q7-Produced HBV e/core Particles Contain Polymerase
Activity. The enzymatic activity of the HBV core-associated
DNA polymerase can be detected when radioactive deoxy-
nucleotides are provided (28, 29). The core-particle fractions
with density -1.34 g/ml purified from the Q7 HBV-21
conditioned medium by using a CsCI gradient incorporated
deoxynucleotides into viral DNAs (Fig. 2, lane 2). The
smearing of signals started at position 4.0 kb of the gel
containing full-length rcDNA. The control culture exhibited
no detectable polymerase activity (Fig. 2, lane 3). Intracel-
lular core particles purified through a sucrose gradient (28)
1 2 3
.w
_0'
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FIG. 1. Southern blot analysis of intracellular and extracellular
HBV-specific DNAs prepared from several hepatoma cell lines
producing Dane-like particles. (A) Intracellular, unintegrated HBV
DNA replicative intermediates including rc- and minus-strand linear
ssDNA as indicated. Vector-free HBV double-stranded DNAs were
radiolabeled and used as probes. Lanes: 1, human HBV-producing
HepG2 hepatoma cell line UP7-4; 2, human HBV-producing HepG2
hepatoma cell line UP7-7; 3, A phage HindIII size marker; 4, rat
hepatoma cell line Q7 HBV-21; 5, rat hepatoma cell line Q7 HBV-5.
(B) Intracellular, unintegrated minus-strand ssDNA replicative in-
termediates were characterized by Southern transfer without prior
alkaline denaturation. Strand-specific probes of HBV DNA in M13
plasmid were used. Only the radiolabeled plus-strand probe could
cross react with the 1.5-kb minus-strand intermediate. Lanes 1-4
correspond to lanes 1-4 in A. (C) Extracellular, virion-associated
DNAs prepared from 10 ml of medium from Q7 HBV-21 cells were
analyzed by Southern procedures. Lanes: 1, A phage HindIII size
markers; 2, Q7 parental cell line; 3, Q7 HBV-21 intracellular DNA;
4, Q7 HBV-21 extracellular DNA.
-RC4.Okb
-wSS
-Is
FIG. 2. Enzymatic assay of HBV endogenous polymerase activ-
ity. Core particles enriched from a CsCI gradient were incubated with
radiolabeled dNTPs. HBV-specific incorporation of radioactivity
was monitored by gel electrophoresis (28, 29). Lanes: 1, A phage
HindIII size markers; 2, core particles from the medium of Q7
HBV-21 cells; 3, negative control medium of the untransfected
parental cell line Q7.
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also exhibited significant polymerase activity (data not
shown).
HBV-Specific RNA Transcripts. Transcription products of
the HBV genome include three major size classes: 3.5, 2.5,
and 2.1 kb (1-3). The 2.1-kb transcript had the strongest
intensity, and the 2.5-kb transcript had the weakest intensity
(Fig. 3, lanes 1-3). This intensity pattern was virtually
indistinguishable from that of a HBV-producing system of
human HepG2 hepatoblastoma cell line (data not shown). No
HBV-specific transcripts were detected in the untransfected
parental cell line Q7 (Fig. 3, lanes 1-3).
In addition to the three transcripts mentioned above, we
have found another transcript at 2.2 kb that cross reacts with
a core-gene-specific probe (positions 1987-2840) (Fig. 3,
lanes 4-6). This transcript was detected in all the HBV-
producing human HepG2 or Q7 rat hepatoma cell lines
examined (data not shown). When the pSV2ANeo vector was
used as a probe on the same Northern blot, a 2.6-kb band
specific to the Neor gene was observed (data not shown).
HBV Dane-like Particles and Subviral Particles. To see ifthe
maturation process ofHBV virion could occur in the stably
transfected cultures of Q7 cells, we examined conditioned
medium from Q7 HBV-21 and Q7 HBV-5 cells by electron
microscopy. The pellet collected from conditioned medium
was fractionated by centrifugation through a cesium chloride
density gradient. Dane-like particles with a double-shell
concentric shape and an averaged diameter of40-46 nm were
observed in fractions at a density of 41.24 g/ml (Fig. 4C)
(30). In addition, the 22-nm spherical and filamentous forms
were observed as well in fractions at a density of =1.20 g/ml
(Fig. 4 A and B). Southern blot analysis indicated that the
Dane-particle fractions (1.34 g/ml density) contain predom-
inantly a 4.0-kb rc form, and the core particle fractions
contain predominantly a 1.5-kb ss form (data not shown).
DISCUSSION
The species origin of these HBV-producing Q7 hepatoma cell
lines was confirmed by the observation that these cells
contain rat-specific repetitive sequences. Upon digestion of
Q7 genomic DNA with BamHI or HindIII, followed by gel
electrophoresis, discrete bands of rat-specific repetitive se-
quences at positions 5.8 kb or 3.8 kb, respectively, can be
seen by ethidium bromide staining (data not shown). These
characteristic bands of rat species are not present in human
1 2 3
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4 5 6
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FIG. 3. Northern blot analysis of total RNAs prepared from
HBV-producing rat hepatoma cell line Q7 HBV-21 and the untrans-
fected parental hepatoma cell line Q7. Vector-free double-stranded
DNA was radiolabeled and used as a probe. Lanes: 1-3, full-length
HBV DNA (positions 1-3182) was used as a probe; 4-6, core-specific
subgenomic DNA (positions 1987-2840) was used as a probe; 1 and
4, Q7 parental cells; 2 and 5, Q7 HBV-21 cells; 3 and 6, A phage
HindIII size markers.
A
C
FIG. 4. Morphological examination of HBV viral and subviral
particles by electron microscopy. Particles are collected from the
conditioned medium of HBV-producing cell lines. HBV surface
antigen particles 22 nm in diameter of spherical (A) or filamentous (B)
shape and 38- to 42-nm Dane-like particles (C) enriched from the
conditioned medium of rat hepatoma cell line Q7 HBV-21. (Bars =
100 nm.)
or mouse genomic DNA when digested with the same re-
striction enzymes. Although woodchucks and squirrels are
among the natural hosts for the hepadnavirus family, other
rodents such as rat or mouse have not been found to be hosts
for any hepadnaviruses under either natural or experimental
conditions. The successful production of Dane-like particles
from transfected Q7 cultures indicates that the species barrier
between human and rat probably resides at the penetration/
absorption step during the early phase of the viral life cycle.
Similar results of cross-species replication of HBV were
reported in the transgenic mice system during the preparation
of this manuscript (16). However, in that system, although
complete viral genome replication was reported, completely
matured Dane-like particles were not detected by electron
microscopy. Our electron microscopic results of Q7 HBV-21
cells (Fig. 4) clearly indicate that even at the steps of viral
morphogenesis or excretion, no species barrier exists be-
tween human and rat systems.
Among the many human and rat hepatoma cell lines being
screened, HepG2, Huh6-c15, and Q7 are the only three cell
lines that appear to be able to sustain the production of
Dane-like particles (4-8). Although Huh7 seems to be a good
host for the transient expression of HBV (7), to our knowl-
edge, no establishment of stable HBV-producing Huh7 cell
lines has yet been documented. Any factor(s) that is critical
to the cellular permissiveness of HBV must be common to
HepG2, Huh6-c15, and Q7 cell lines. The establishment of a
stable culture with active HBV propagation in HepG2 has led
to the speculation that a well-differentiated environment may
be required for HBV production (4, 5). Although the Q7 rat
hepatoma cell line retains the ability to produce serum
albumin or a-fetoprotein, the degree of differentiation of Q7
Proc. Natl. Acad Sci. USA 86 (1989)
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cells is not comparable to that of HepG2 cells (26, 27). The
relationship between cellular differentiation and viral prop-
agation remains to be elucidated.
The ccc form of HBV DNA has been found in the liver of
HBV-infected patients (31). This ccc form is believed to serve
as a transcription template and will accumulate during the
early phase of infection (32). Although we have detected
extra bands of HBV-specific DNA in Q7 HBV-21 but not in
HBV-producing HepG2 cells (Fig. LA), these bands did not
appear to be cccDNA upon further characterization (unpub-
lished results). It is possible that the synthesis of the prege-
nomic RNA was from the multiple copies of integrated HBV
DNA on the Q7 chromosome (data not shown), rather than
from unintegrated cccDNA. Similar results were reported for
the human HepG2 systems (5-8). The infectivity of the
Dane-like particles produced from the Q7 HBV-21 system
was confirmed by injection of conditioned medium into
chimpanzee (unpublished results).
It is possible that the 2.2-kb transcript is derived from
splicing the 3.5-kb pregenomic RNA (33). The fact that the
vector probe alone will not hybridize with this transcript
suggests very strongly that this transcript is not generated by
initiation from or termination within the cloning vector (Fig.
3). The possibility that this transcript is produced as a
virus/cell hybrid transcript from the integrated HBV DNA in
Q7 HBV-21 cells also seems highly unlikely. Of four HBV-
producing cell lines (either of human or rat origin) that were
examined, all contained this transcript comigrating at 2.2 kb
(data not shown). The biological significance ofthis transcript
remains to be investigated.
The rat Q7 HBV-production system potentially will offer
several major advantages over the human HepG2 system: (i)
It makes possible a fair comparison of the tumor incidence
between HBV-producing and nonproducing rat hepatoma
cell lines with almost identical genetic backgrounds. (ii) It
provides the potential of establishing an animal model to
study the immunology of a tumor-bearing rat with active
HBV production. The fact that the inbred rat is readily
available will allow one to more conveniently study the im-
munological aspects of HBV-associated hepatocellular carci-
noma. (iii) It provides a system to study the activities of viral
integration and replication during the process of tumor pro-
gression in animals.
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